相似文献
1
Up or down: where comes Omicron?
Cell Res. 2022 Jul;32(7):601-602. doi: 10.1038/s41422-022-00675-1.
2
Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain.
Nat Commun. 2022 Mar 3;13(1):1214. doi: 10.1038/s41467-022-28882-9.
3
COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles.
Infect Dis Rep. 2022 Jun 17;14(3):492-500. doi: 10.3390/idr14030052.
4
Distinct Core Glycan and O-Glycoform Utilization of SARS-CoV-2 Omicron Variant Spike Protein RBD Revealed by Top-Down Mass Spectrometry.
bioRxiv. 2022 Apr 18:2022.02.09.479776. doi: 10.1101/2022.02.09.479776.
5
Distinct core glycan and -glycoform utilization of SARS-CoV-2 Omicron variant Spike protein RBD revealed by top-down mass spectrometry.
Chem Sci. 2022 Aug 31;13(36):10944-10949. doi: 10.1039/d2sc02132c. eCollection 2022 Sep 21.
6
3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study.
Lancet Respir Med. 2024 Jan;12(1):55-66. doi: 10.1016/S2213-2600(23)00387-9. Epub 2023 Nov 21.
7
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies.
Cell Discov. 2022 Oct 7;8(1):104. doi: 10.1038/s41421-022-00463-6.
8
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
Lancet. 2023 Mar 11;401(10379):833-842. doi: 10.1016/S0140-6736(22)02465-5. Epub 2023 Feb 16.
9
Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain.
Cell Rep Med. 2022 Jan 24;3(2):100527. doi: 10.1016/j.xcrm.2022.100527. eCollection 2022 Feb 15.
10
Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function.
bioRxiv. 2022 Jan 18:2022.01.14.476382. doi: 10.1101/2022.01.14.476382.
引用本文的文献
1
Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants.
MedComm (2020). 2025 Jul 7;6(7):e70273. doi: 10.1002/mco2.70273. eCollection 2025 Jul.
2
Cooperative and structural relationships of the trimeric Spike with infectivity and antibody escape of the strains Delta (B.1.617.2) and Omicron (BA.2, BA.5, and BQ.1).
J Comput Aided Mol Des. 2023 Dec;37(12):585-606. doi: 10.1007/s10822-023-00534-0. Epub 2023 Oct 4.
3
SARS-CoV-2 and animals, a long story that doesn't have to end now: What we need to learn from the emergence of the Omicron variant.
Front Vet Sci. 2022 Dec 15;9:1085613. doi: 10.3389/fvets.2022.1085613. eCollection 2022.
4
Development of variant-proof severe acute respiratory syndrome coronavirus 2, pan-sarbecovirus, and pan-β-coronavirus vaccines.
J Med Virol. 2023 Jan;95(1):e28172. doi: 10.1002/jmv.28172. Epub 2022 Oct 6.
5
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.
Signal Transduct Target Ther. 2022 Jul 19;7(1):241. doi: 10.1038/s41392-022-01105-9.
本文引用的文献
1
Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody.
Science. 2022 Mar 4;375(6584):1048-1053. doi: 10.1126/science.abn8863. Epub 2022 Feb 8.
2
Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant.
Cell Res. 2022 Apr;32(4):404-406. doi: 10.1038/s41422-022-00617-x. Epub 2022 Jan 27.
3
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement.
Science. 2022 Feb 25;375(6583):864-868. doi: 10.1126/science.abn8652. Epub 2022 Jan 25.
4
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Nature. 2022 Feb;602(7898):664-670. doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23.
5
Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
EBioMedicine. 2021 May;67:103381. doi: 10.1016/j.ebiom.2021.103381. Epub 2021 May 14.
6
A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
Cell. 2020 Nov 12;183(4):1070-1085.e12. doi: 10.1016/j.cell.2020.09.050. Epub 2020 Sep 23.
7
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.
Science. 2020 Sep 25;369(6511):1603-1607. doi: 10.1126/science.abc4730. Epub 2020 Jul 30.
Zotero 插件